Mersana Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRSN and other ETFs, options, and stocks.

About MRSN

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592.

CEO

Martin H. Huber

CEOMartin H. Huber

Employees

102

Employees102

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2001

Founded2001

Employees

102

Employees102

MRSN Key Statistics

Market cap

46.33M

Market cap46.33M

Price-Earnings ratio

-0.70

Price-Earnings ratio-0.70

Dividend yield

—

Dividend yield—

Average volume

2.33M

Average volume2.33M

High today

$0.396

High today$0.396

Low today

$0.36

Low today$0.36

Open price

$0.3878

Open price$0.3878

Volume

418.67K

Volume418.67K

52 Week high

$3.63

52 Week high$3.63

52 Week low

$0.2589

52 Week low$0.2589

Analyst ratings

89%

of 9 ratings

Buy

88.9%

Hold

11.1%

Sell

People also own

Based on the portfolios of people who own MRSN. This list is generated using Robinhood data, and it’s not a recommendation.